Merck KGaA (MKKGY)
OTCMKTS · Delayed Price · Currency is USD
30.43
-0.48 (-1.55%)
Jan 28, 2026, 4:00 PM EST
Merck KGaA Revenue
Merck KGaA had revenue of 5.32B EUR in the quarter ending September 30, 2025, with 0.99% growth. This brings the company's revenue in the last twelve months to 21.27B, up 1.47% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.27B EUR
Revenue Growth
+1.47%
P/S Ratio
2.64
Revenue / Employee
341.18K EUR
Employees
62,346
Market Cap
65.92B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
| Growth Stalk Holdings | 583.34K |
Merck KGaA News
- 13 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 16 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor - Benzinga
- 6 weeks ago - Why Immunome, A Top 3% Stock, Just Rocketed On Its Rivalry With Merck KGaA - Investor's Business Daily
- 6 weeks ago - Thin-Film Electrode Market worth $0.97 billion by 2030 at 11.3%, says MarketsandMarkets™ - Benzinga
- 2 months ago - Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case - WSJ
- 2 months ago - Dr. Rasha Kelej of Merck Foundation Meets Nigeria First Lady at the Merck Foundation Africa Asia Luminary 2025 - Business Upturn
- 2 months ago - Merck Foundation Observes the ‘Day for Elimination of Violence Against Women 2025’ Through Their More Than a Mother Campaign and Educating Linda Program - Business Upturn